Brendon Ross
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Brendon Ross has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Joel A. Block
Division of Rheumatology, Rush University, Chicago, USA
2 shared publications Magdalena Anitescu
Department of Anesthesia & Critical Care, Section of Pain Medicine, University of Chicago Medicine, Chicago, Illinois
2 shared publications- Osman Ahmed
Joint and Vascular Institute, Libertyville, Illinois; Department of Radiology, Division of Interventional Radiology, University of Utah, Salt Lake City, Utah
2 shared publications - Akhilesh Keshav Sista
Department of Radiology, Weill Cornell Medicine, New York, New York
1 shared publication - Bedros Taslakian
Department of Interventional Radiology, University of Miami Miller School of Medicine, Miami, Florida
1 shared publication Charles Ray
Department of Radiology and Imaging Sciences, Spencer Fox Eccles School of Medicine at University of Utah Health, Salt Lake City, Utah
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 12 May 2026
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 37 (7) , 108803
Society of Interventional Radiology Position Statement on Genicular Artery Embolization for Symptomatic Knee Osteoarthritis
- 12 May 2026
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 37 (7) , 108803
Top Cited PapersOpen AccessSociety of Interventional Radiology Position Statement on Genicular Artery Embolization for Symptomatic Knee Osteoarthritis
- Open Access
- 11 December 2023
- Published by Wiley in Translational Sports Medicine
- Vol. 2023, 1-6
Physician Perceptions of Cannabidiol (CBD) and Cannabis in Sports Medicine and Performance
Objectives. There is growing evidence regarding cannabinoid use in sports medicine and performance, especially cannabidiol (CBD). This study aims to determine if sports medicine physicians are recommending cannabinoids for therapeutic purposes, as well as analyze perceptions of cannabinoids within sports medicine and performance. Methods. Physician members of the American Medical Society for Sports Medicine (AMSSM) completed an anonymous survey on demographics, CBD and Cannabis recommendations, as well as attitudes toward cannabinoid products within sports medicine. Factors associated with CBD and cannabis recommendations as well as perceptual differences were found using multivariate regression modelling. Results. Responses from 333 physicians were recorded. The following groups were less likely to agree with allowing cannabis for recreational purposes: female gender (coeff. = 0.79 (0.33–1.25), ), increasing age (coeff. = 0.04 (0.02, 0.07), ), and rural respondents (compared to baseline urban, coeff. = 1.16 (0.36, 1.95), ). Similarly, these three factors were associated with a higher likelihood of disagreeing with WADA removing cannabis from the prohibited substance list and with the NCAA allowing CBD use by collegiate athletes ( ). CBD was less likely to be recommended by pediatricians, rural physicians, and academic physicians ( ). Male physicians and younger physicians were less likely to identify cannabis as performance-enhancing ( ). Conclusions. Sports medicine physicians have varying views on cannabinoids. While sports medicine physicians generally have favorable attitudes toward CBD and cannabis, these perceptions appear to be significantly affected by age, practice type, and gender.
- 11 December 2023
- Published by Wiley in Translational Sports Medicine
- Vol. 2023, 1-6
Open AccessPhysician Perceptions of Cannabidiol (CBD) and Cannabis in Sports Medicine and Performance
Objectives. There is growing evidence regarding cannabinoid use in sports medicine and performance, especially cannabidiol (CBD). This study aims to determine if sports medicine physicians are recommending cannabinoids for therapeutic purposes, as well as analyze perceptions of cannabinoids within sports medicine and performance. Methods. Physician members of the American Medical Society for Sports Medicine (AMSSM) completed an anonymous survey on demographics, CBD and Cannabis recommendations, as well as attitudes toward cannabinoid products within sports medicine. Factors associated with CBD and cannabis recommendations as well as perceptual differences were found using multivariate regression modelling. Results. Responses from 333 physicians were recorded. The following groups were less likely to agree with allowing cannabis for recreational purposes: female gender (coeff. = 0.79 (0.33–1.25), ), increasing age (coeff. = 0.04 (0.02, 0.07), ), and rural respondents (compared to baseline urban, coeff. = 1.16 (0.36, 1.95), ). Similarly, these three factors were associated with a higher likelihood of disagreeing with WADA removing cannabis from the prohibited substance list and with the NCAA allowing CBD use by collegiate athletes ( ). CBD was less likely to be recommended by pediatricians, rural physicians, and academic physicians ( ). Male physicians and younger physicians were less likely to identify cannabis as performance-enhancing ( ). Conclusions. Sports medicine physicians have varying views on cannabinoids. While sports medicine physicians generally have favorable attitudes toward CBD and cannabis, these perceptions appear to be significantly affected by age, practice type, and gender.